Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Formosa Chemicals and Fibre Corporation (FCFC) is a prominent Taiwanese industrial company and a key member of the Formosa Plastics Group. Primarily operating in the petrochemical and synthetic fiber industries, FCFC has expanded its reach into the life sciences sector through its subsidiary, Formosa Biomedical Technology Corporation. The company manufactures high-purity chemical precursors and medical-grade plastics used in the production of medical devices, labware, and pharmaceutical packaging. Additionally, its biomedical arm focuses on clinical diagnostics, regenerative medicine, and the development of therapeutic antibodies. FCFC leverages its extensive manufacturing infrastructure to provide integrated solutions for the global healthcare and biotechnology markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Formosa Chemicals and Fibre Corporation.